Polypipe Group /£GEN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Polypipe Group

Polypipe Group, trading under the ticker GEN, is a manufacturer specializing in water management and plastic piping systems. Established in 1980, the company operates primarily within the construction and infrastructure sectors. Polypipe offers a wide range of products aimed at addressing critical challenges in water, climate, and ventilation management, contributing to the development of green building solutions.

Ticker

£GEN

Primary listing

LSE

Industry

Building Products

Employees

3,200

ISIN

GB00BKRC5K31

Polypipe Group Metrics

BasicAdvanced
£951M
28.61
£0.13
1.35
£0.13
3.29%

What the Analysts think about Polypipe Group

Analyst ratings (Buy, Hold, Sell) for Polypipe Group stock.

Bulls say / Bears say

Analysts have a consensus 'Buy' rating on Genuit Group plc, with an average 12-month price target of 472.56 GBP, indicating a potential upside of approximately 26.86% (Investing.com).
The company has demonstrated strong revenue growth, with net sales projected to increase from 585 million GBP in 2025 to 614 million GBP in 2026, reflecting a positive growth trajectory (MarketScreener).
Genuit Group's diversified product portfolio, including sustainable water, climate, and ventilation solutions, positions it well to capitalize on increasing demand for environmentally friendly building products (MarketScreener).
The company's trailing P/E ratio of 27.6x is significantly higher than the industry average of 15.3x, suggesting potential overvaluation and limited room for stock appreciation (Investing.com).
Despite revenue growth, net debt remains substantial at 111 million GBP in 2025, which could pose financial risks if not managed effectively (MarketScreener).
The stock has been underperforming compared to the broader market, with 67% of all stocks performing better over the past year, indicating potential investor concerns about the company's future prospects (ChartMill).
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.

Polypipe Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Polypipe Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £GEN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs